V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017932 | 220009102 | 1.71 | 78.2 | Curative (C) | 2017-08-01 | 2017-08-24 | GEMTUZUMAB OZOGAMICIN | 99 | N | 220034266 | IRINOTECAN + MDG |
| 220017933 | 220014856 | 1.74 | 68.3 | Palliative (P) | 2017-02-25 | 2017-03-15 | IDARUBICIN | N | N | 220034274 | IDARUBICIN |
| 220017936 | 220009109 | 1.67 | 83 | Palliative (P) | 2015-02-16 | 2015-02-16 | Carboplatin + Etoposide iv&po | 02 | N | 220034296 | CARBOPLATIN + ETOPOSIDE |
| 220017937 | 220019941 | null | 108.5 | Curative (C) | 2016-01-30 | 2016-01-31 | IDARUBICIN | null | null | 220034302 | IDARUBICIN |
| 220017938 | 220009112 | 1.88 | 59.3 | Palliative (P) | 2016-01-25 | 2016-02-08 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220034322 | ALEMTUZUMAB |
| 220017939 | 220009113 | 1.82 | 81.4 | Curative (C) | 2014-04-05 | 2014-04-06 | FLUOROURACIL + OXALIPLATIN | 2 | N | 220034334 | UKALL2014 |
| 220017940 | 220009116 | 1.75 | 86.5 | Curative (C) | 2016-08-06 | 2016-08-31 | FLUDARABINE + MELPHALAN | Y | N | 220034337 | CISPLATIN + GEMCITABINE |
| 220017941 | 220018115 | 1.69 | 101.099 | Curative (C) | 2013-06-09 | 2013-06-18 | Alemtuzumab cond (RI ALLO CAMP100) | null | null | 220034340 | ALEMTUZUMAB |
| 220017942 | 220009117 | 1.73 | 78.2 | Palliative (P) | 2013-11-15 | 2013-11-22 | GEMTUZUMAB OZOGAMICIN | 2 | N | 220034342 | ECX |
| 220017943 | 220009120 | 1.61 | 48.7 | Curative (C) | null | 2014-01-31 | Carboplatin 21day + Paclitaxel 7day | 2 | N | 220034352 | CARBOPLATIN + PACLITAXEL |
| 220017944 | 220009123 | 1.5 | 54 | Disease modification (D) | 2015-10-02 | 2015-10-07 | Carboplatin + Paclitaxel (weekly) | N | N | 220034356 | CARBOPLATIN + PACLITAXEL |
| 220017945 | 220018118 | 1.69 | 55.8 | Palliative (P) | 2017-12-04 | 2017-12-04 | Clofarabine + Cytarabine | N | N | 220034364 | GEMCARBO |
| 220017947 | 220009132 | 0 | 63.1 | Curative (C) | null | 2017-03-10 | IDARUBICIN | Y | N | 220034423 | IDARUBICIN |
| 220017948 | 220018119 | 1.71 | 75 | Curative (C) | 2018-06-12 | 2018-06-12 | CARBOPLATIN + GEMCITABINE | null | null | 220034424 | PONATINIB |
| 220017949 | 220009139 | 1.81 | null | Curative (C) | 2015-08-01 | 2015-08-02 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220034425 | ALEMTUZUMAB |
| 220017950 | 220009141 | null | 81.7 | null | 2017-10-20 | 2017-10-25 | Cytarabine intrathecal | N | N | 220034425 | CYTARABINE INTRATHECAL |
| 220017951 | 220009143 | 1.65 | null | Disease modification (D) | 2017-11-07 | 2018-02-11 | Arsenic Triox + Tretinoin Ind W5-8 | 02 | N | 220034436 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017952 | 220009146 | 1.57 | 58.1 | Curative (C) | 2017-02-15 | 2017-04-27 | FLUOROURACIL + OXALIPLATIN | null | null | 220034440 | IRINOTECAN + MDG |
| 220017953 | 220009147 | null | 71 | Curative (C) | 2016-05-18 | 2016-05-18 | PONATINIB | null | null | 220034440 | FLUDARABINE + MELPHALAN |
| 220017954 | 220009150 | null | 97.2 | Curative (C) | 2017-09-08 | 2017-09-19 | CARBOPLATIN + ETOPOSIDE | N | N | 220034452 | CARBOPLATIN + ETOPOSIDE |
| 220017956 | 220009152 | null | 74 | Palliative (P) | 2017-01-17 | 2017-01-22 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN | N | null | 220034482 | LENALIDOMIDE |
| 220017957 | 220009155 | null | 95.4 | Palliative (P) | 2017-06-20 | 2017-07-01 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 220034483 | CETUXIMAB |
| 220017958 | 220009155 | 1.91 | 103.75 | null | 2012-10-23 | 2013-06-21 | MidAC | 02 | null | 220034483 | IGEV R |
| 220017960 | 220009159 | 1.75 | 63.6 | Palliative (P) | 2014-08-06 | 2014-08-09 | CETUXIMAB + IRINOTECAN + MDG | N | Y | 220034495 | MELPHALAN |
| 220017961 | 220009167 | null | null | Curative (C) | null | 2018-06-24 | Carboplatin + Cetux + FU (>Cycle 2) | null | null | 220034498 | IMATINIB + HYDROXYCARBAMIDE |
| 220017962 | 220014883 | null | null | null | 2013-10-09 | 2013-10-15 | FLA | 02 | N | 220034505 | CARBOPLATIN |
| 220017963 | 220009168 | 1.67 | 70 | Disease modification (D) | 2019-03-11 | 2019-04-20 | CISPLATIN + ETOPOSIDE | 2 | N | 220034510 | ARSENIC TRIOXIDE |
| 220017964 | 220009169 | 1.81 | 71.9 | Curative (C) | 2014-12-21 | 2015-01-11 | VINORELBINE | 2 | N | 220034510 | ALEMTUZUMAB + FLUDARABINE |
| 220017965 | 220009169 | null | null | Curative (C) | 2016-07-04 | 2016-07-11 | Spanish Maintenance (Months 1-3) | N | null | 220034510 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN |
| 220017966 | 220009169 | 1.75 | 102.4 | Curative (C) | 2015-02-20 | 2015-02-20 | CHOP R - 14 days | 2 | N | 220034510 | CETUXIMAB |
| 220017967 | 220022218 | null | 17.5 | Palliative (P) | 2013-09-20 | 2013-09-20 | VINCRISTINE | 99 | null | 220034521 | FIGARO TRIAL |
| 220017968 | 220009172 | 1.69 | 44.8 | Curative (C) | 2013-08-11 | 2013-10-25 | EVEROLIMUS | 02 | N | 220034524 | BUSULPHAN |
| 220017969 | 220014886 | 1.69 | 62.8 | Curative (C) | 2016-09-04 | 2017-06-04 | Folfirinox | N | N | 220034531 | BEP |
| 220017970 | 220009177 | 1.58 | 80 | Palliative (P) | 2016-07-25 | 2016-08-23 | MITOXANTRONE + TRETINOIN | null | null | 220034543 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 220017971 | 220009178 | 0 | 78.4 | Palliative (P) | 2015-11-06 | 2015-11-15 | DACTINOMYCIN | N | N | 220034552 | ROMAZA TRIAL |
| 220017972 | 220009179 | 1.74 | null | Palliative (P) | 2013-12-02 | 2013-12-02 | Capecitabine | N | null | 220034562 | CVD |
| 220017973 | 220009181 | 1.69 | 80.4 | Curative (C) | 2015-06-08 | 2015-06-08 | Mercaptopurine | 02 | null | 220034567 | DABRAFENIB + TRAMETINIB |
| 220017974 | 220009184 | 1.61 | 115.4 | Palliative (P) | 2016-01-19 | 2016-01-19 | FIGARO TRIAL | N | N | 220034571 | ARSENIC TRIOXIDE + ATRA |
| 220017975 | 220009187 | 1.8 | 101.8 | Disease modification (D) | 2018-03-11 | 2018-09-16 | MA (Cytarabine 3g/m2) | N | Y | 220034579 | MA |
| 220017976 | 220018130 | 0 | 126.3 | Curative (C) | 2015-09-02 | 2016-02-02 | MITOMYCIN | 02 | N | 220034588 | VENETOCLAX |
| 220017977 | 220009190 | 1.77 | 90 | Palliative (P) | 2014-11-18 | 2014-11-18 | ALL UKALL60+ TRIAL | 02 | N | 220034596 | VINORELBINE |
| 220017978 | 220009192 | null | 82.8 | Disease modification (D) | 2015-05-23 | 2015-05-31 | BUSULFAN + CYCLOPHOSPHAMIDE | 2 | N | 220034605 | BUSULFAN + CYCLOPHOSPHAMIDE |
| 220017979 | 220009193 | 1.66 | 63.3 | Curative (C) | null | 2016-06-04 | ALEMTUZUMAB + FLUDARABINE | N | Y | 220034611 | CAPECITABINE |
| 220017980 | 220009195 | null | 74 | Palliative (P) | 2017-09-07 | 2017-09-07 | Methotrexate High Dose (3g/m2) | 02 | null | 220034611 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE |
| 220017981 | 220009195 | 1.67 | 78.4 | Curative (C) | 2016-02-01 | 2018-03-10 | PEMBROLIZUMAB | N | N | 220034611 | FEC |
| 220017983 | 220009197 | 1.76 | 88 | null | 2015-05-16 | 2015-06-22 | EEF or EOF | 02 | N | 220034623 | CAPECITABINE + TEMOZOLOMIDE |
| 220017984 | 220009201 | 1.68 | null | Palliative (P) | 2016-10-12 | 2016-10-14 | Epirubicin | null | N | 220034635 | CLOFARABINE + DAUNORUBICIN |
| 220017985 | 220014898 | 2 | 94 | Curative (C) | 2017-12-27 | 2018-01-04 | Arsenic Triox + Tretinoin Ind W1-4 | N | N | 220034662 | UKALL2011 |
| 220017986 | 220009207 | 1.61 | 57.1 | Curative (C) | 2013-12-23 | 2013-12-23 | Arsenic Triox + Tretinoin Ind W1-4 | N | N | 220034670 | GCLAC |
| 220017988 | 220009211 | 1.76 | 72 | Palliative (P) | 2015-10-02 | 2015-10-13 | Cetuximab 7 day (>Cycle 2) | 02 | N | 220034675 | CODOX M |